JP7231540B2 - 生体分子の可逆的保護のための試薬 - Google Patents

生体分子の可逆的保護のための試薬 Download PDF

Info

Publication number
JP7231540B2
JP7231540B2 JP2019523188A JP2019523188A JP7231540B2 JP 7231540 B2 JP7231540 B2 JP 7231540B2 JP 2019523188 A JP2019523188 A JP 2019523188A JP 2019523188 A JP2019523188 A JP 2019523188A JP 7231540 B2 JP7231540 B2 JP 7231540B2
Authority
JP
Japan
Prior art keywords
group
substituted
biomolecule
unsubstituted
protected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019523188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019522058A (ja
JPWO2018011527A5 (https=
JP2019522058A5 (https=
Inventor
ウルスギ，シルヴァン
ロラン，アラン
ラヨン，アリ
ファビ，フレデリック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of JP2019522058A publication Critical patent/JP2019522058A/ja
Publication of JPWO2018011527A5 publication Critical patent/JPWO2018011527A5/ja
Publication of JP2019522058A5 publication Critical patent/JP2019522058A5/ja
Application granted granted Critical
Publication of JP7231540B2 publication Critical patent/JP7231540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2019523188A 2016-07-13 2017-07-13 生体分子の可逆的保護のための試薬 Active JP7231540B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1656791A FR3053968A1 (fr) 2016-07-13 2016-07-13 Reactifs pour la protection reversible de molecules biologiques
FR1656791 2016-07-13
PCT/FR2017/051925 WO2018011527A1 (fr) 2016-07-13 2017-07-13 Réactifs pour la protection réversible de molécules biologiques

Publications (4)

Publication Number Publication Date
JP2019522058A JP2019522058A (ja) 2019-08-08
JPWO2018011527A5 JPWO2018011527A5 (https=) 2022-09-14
JP2019522058A5 JP2019522058A5 (https=) 2022-09-14
JP7231540B2 true JP7231540B2 (ja) 2023-03-01

Family

ID=57286588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019523188A Active JP7231540B2 (ja) 2016-07-13 2017-07-13 生体分子の可逆的保護のための試薬

Country Status (7)

Country Link
US (1) US11708375B2 (https=)
EP (1) EP3484891B1 (https=)
JP (1) JP7231540B2 (https=)
CN (1) CN109831913B (https=)
ES (1) ES2878581T3 (https=)
FR (1) FR3053968A1 (https=)
WO (1) WO2018011527A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230322804A1 (en) * 2016-07-13 2023-10-12 bioMérieux Reagents for reversibly protecting biological molecules
CA3020818C (en) 2017-10-13 2020-10-20 Smith Optics, Inc. Goggle with replaceable lens
CN116410951A (zh) * 2021-12-30 2023-07-11 广州达安基因股份有限公司 一种提高化学修饰的Taq酶的活性的方法和经该方法处理的Taq酶

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529100A (ja) 2007-06-07 2010-08-26 サノフイ−アベンテイス アデノシンａ３受容体リガンドとしてのトリアゾロ［１，５−ａ］キノリン
WO2016003929A1 (en) 2014-07-01 2016-01-07 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1257526A (fr) 1960-05-23 1961-03-31 Leffman Ltd S Perfectionnements apportés aux soutien-gorge
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
AU2003300956A1 (en) * 2002-12-11 2004-06-30 Smithkline Beecham Corporation Anti-infectives
WO2009151921A1 (en) 2008-05-27 2009-12-17 Trilink Biotechnologies Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid
US8800174B2 (en) 2010-07-13 2014-08-12 Mission Product Holdings, Inc. Shoe soles for enhancing gripping with a smooth hard surface
WO2012094343A1 (en) 2011-01-05 2012-07-12 Trilink Biotechnologies Chemically substituted thermosensitive probes and cofactors for hot start ligation
FR2994184B1 (fr) * 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529100A (ja) 2007-06-07 2010-08-26 サノフイ−アベンテイス アデノシンａ３受容体リガンドとしてのトリアゾロ［１，５−ａ］キノリン
WO2016003929A1 (en) 2014-07-01 2016-01-07 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Eur J Med Chem，1993年，28，505-511
ISIDOR MORRIS HEILBRON，CCXCII.―CHEMICAL REACTIVITY AND CONJUGATION. PART II. THE REACTIVITY OF THE 以下備考，JOURNAL OF THE CHEMICAL SOCIETY，1925年，VOL:127，PAGE(S):2167 - 2175，http://dx.doi.org/10.1039/CT9252702167，2-METHYL GROUP IN THE 4-QUINAZOLONE SERIES
J. Org. Chem.，1998年，63，6797-6801
REGISTRY(STN)[online]，2016年02月22日，RN:1871509-91-9、［検索日2021/06/22］

Also Published As

Publication number Publication date
JP2019522058A (ja) 2019-08-08
US11708375B2 (en) 2023-07-25
US20190375763A1 (en) 2019-12-12
ES2878581T3 (es) 2021-11-19
EP3484891B1 (fr) 2021-04-14
CN109831913A (zh) 2019-05-31
CN109831913B (zh) 2022-01-21
WO2018011527A1 (fr) 2018-01-18
WO2018011527A9 (fr) 2018-05-03
EP3484891A1 (fr) 2019-05-22
FR3053968A1 (fr) 2018-01-19

Similar Documents

Publication Publication Date Title
US12227775B2 (en) Modified template-independent DNA polymerase
Castanedo et al. Synthesis of tetrasubstituted thiophenes on solid-support using the Gewald reaction
JP7231540B2 (ja) 生体分子の可逆的保護のための試薬
JP2009513135A (ja) エンコードされたライブラリーを用いて興味のある化合物を同定する方法
JP2011148833A (ja) 抗ウィルス剤の機能を有する両複素環連結化合物および当該化合物を含有する組成物の、ウィルス性疾患の治療における応用
JP2009544660A (ja) 合成プローブによる融合タンパク質の標識化
JP2014039550A (ja) コードされたライブラリーの合成のための方法
Liu et al. Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization
US10508274B2 (en) Protein and peptide libraries
Sydnes et al. Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors
JP7523164B2 (ja) コロナウイルス３ｃｌプロテアーゼを標的とするｐｒｏｔａｃ、およびその調製方法と応用
US20230322804A1 (en) Reagents for reversibly protecting biological molecules
Talukder et al. Synthesis of alanyl nucleobase amino acids and their incorporation into proteins
EP1806400B1 (en) Inactivation method
Wodtke et al. Solution-phase synthesis of the fluorogenic TGase 2 acyl donor Z-Glu (HMC)-Gly-OH and its use for inhibitor and amine substrate characterisation
JP2009221168A (ja) ヌクレオシドまたはヌクレオチド誘導体、核酸誘導体、標的物質捕捉材料、標的物質を捕捉および／または放出する方法、ならびにヘミンアプタマー
Fukumoto et al. Development of a solid-supported biotinylation reagent for efficient biotin labeling of SH groups on small molecules
KR20230079375A (ko) 핵산 변형 시약 및 이의 용도
JP2982621B2 (ja) 光増感機能をもつ新規アミノ酸
RU2380417C2 (ru) Средство для ингибирования фермента 8-оксогуанин-днк-гликозилазы человека
JP7104399B2 (ja) 光反応性人工アミノ酸、及び光架橋性人工ポリペプチド
Zhao et al. A new efficient synthesis of n-(2-(2-(3-methoxy-4-(oxazol-5-yl) phenylamino) oxazol-5-yl) phenyl)-N-methyl-2-morpholinoacetamide (BMS-337197), a novel IMPDH inhibitor
HK40104266A (zh) 具有光开裂性部位的化合物、连结体和应用其的筛选方法
WO2023004046A1 (en) Compounds and methods for detection of superoxide
Komissarov et al. Polymethylene derivatives of nucleic bases bearing ω-functional groups: IX—An unusual reaction of methyl 2-thiocyano-5-chloropentanoate with uracyl and thymine

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210629

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210922

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211118

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220405

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20220804

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220804

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220804

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220905

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230216

R150 Certificate of patent or registration of utility model

Ref document number: 7231540

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250